2020


  1. Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH, Verlohren S (2020). From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach. Ultrasound Obstet Gynecol, 55(1), 5-12.
     
  2. Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH, Verlohren S (2020). From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach. Ultrasound Obstet Gynecol, 55(1), 5-12.
     


  3. 2019


  4. Dathan-Stumpf A, Vogel M, Jank A, Thiery J, Kiess W, Stepan H (2019). Reference intervals of serum lipids in the second and third trimesters of pregnancy in a Caucasian cohort: the LIFE Child study. Arch Gynecol Obstet, 300(6), 1531-1539.
     
  5. Schmitz J, Stepan H, Schrey-Petersen S, Hoffmann J (2019). [Does Lower Uterine Segment Thickness Measurement Improve Birth Planning After Previous Cesarean Section?] Z Geburtshilfe Neonatol, 223(6), 350-358.
     
  6. Hoffmann J, Exner M, Bremicker K, Grothoff M, Stumpp P, Stepan H (2019). Comparison of the lower uterine segment in pregnant women with and without previous cesarean section in 3?T MRI. BMC Pregnancy Childbirth, 19(1), 160-.
     
  7. Stepan H, Hund M, Dilba P, Sillman J, Schlembach D (2019). Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable? Clin Chem Lab Med, 57(9), 1339-1348.
     
  8. Bernstein U, Kaiser T, Stepan H, Jank A (2019). The immature platelet fraction in hypertensive disease during pregnancy. Arch Gynecol Obstet, 299(6), 1537-1543.
     
  9. Lehnig F, Nagl M, Stepan H, Wagner B, Kersting A (2019). Associations of postpartum mother-infant bonding with maternal childhood maltreatment and postpartum mental health: a cross-sectional study. BMC Pregnancy Childbirth, 19(1), 278-.
     
  10. Seidel V, Gurbuz B, Grosskreutz C, Vortel M, Borde T, Rancourt RC, Stepan H, Sauzet O, Henrich W, David M (2019). The influence of migration on women's use of different aspects of maternity care in the German health care system: Secondary analysis of a comparative prospective study with the Migrant Friendly Maternity Care Questionnaire (MFMCQ). Birth, 3, 555-567.
     
  11. Schramm K, Grassl N, Nees J, Hoffmann J, Stepan H, Bruckner T, Haun MW, Maatouk I, Haist M, Schott TC, Sohn C, Schott S (2019). Women's Attitudes Toward Self-Monitoring of Their Pregnancy Using Noninvasive Electronic Devices: Cross-Sectional Multicenter Study. JMIR Mhealth Uhealth, 7(1), 11458-.
     
  12. Zeisler H, Llurba E, Chantraine FJ, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Schoedl M, Grill S, Hund M, Verlohren S (2019). Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting. Ultrasound Obstet Gynecol, 53(3), 367-375.
     
  13. Lewis CA, Kimmig AS, Zsido RG, Jank A, Derntl B, Sacher J (2019). Effects of Hormonal Contraceptives on Mood: A Focus on Emotion Recognition and Reactivity, Reward Processing, and Stress Response. Curr Psychiatry Rep, 21(11), 115-.
     


  14. 2018


  15. Hoffmann J, Exner M, Bremicker K, Grothoff M, Stumpp P, Schrey-Petersen S, Stepan H (2018). Cesarean section scar in 3 T magnetic resonance imaging and ultrasound: image characteristics and comparison of the methods. Arch Gynecol Obstet, 0, 0.
     
  16. Wolf B, Krasselt M, de Fallois J, von Braun A, Stepan H (2018). Tuberculosis in Pregnancy ? a Summary Geburtshilfe und Frauenheilkunde, 0, 01-19.
     
  17. Schmitz J, Stepan H, Schrey-Petersen S, Hoffmann J (2018). Verbessert die Diagnostik des unteren Uterinsegments die Geburtsplanung bei Status nach Sectio? Zeitschrift für Geburtshilfe und Perinatologie, 0, 0.
     
  18. Weber ML, Schaarschmidt W, Thadhani R, Stepan H (2018). Cerebroplacental ratio and fetal response to maternal extracorporeal soluble fms-like tyrosine kinase-1 removal. Ultrasound Obstet Gynecol, 52(3), 405-406.
     
  19. Hoffmann J, Stumpp P, Exner M, Grothoff M, Stepan H (2018). Magnetic resonance imaging can be useful for advanced diagnostic of the lower uterine segment in patients after previous cesarean section. Ultrasound Obstet Gynecol, 0, 0.
     
  20. Dathan-Stumpf A, Faber R, Stepan H (2018). Abnorm invasive Plazenta: klinisches Management Frauenarzt 2018, 9, 674–677.
     
  21. Heihoff-Klose A (2018). Wie steht es um die Episiotomie in der Geburtsmedizin? Bayerisches Ärzteblatt, 10, 0.
     
  22. Hanschmidt F, Hoffmann R, Klingner J, Kersting A, Stepan H (2018). Help-seeking Following Termination of Pregnancy after Diagnosis of Fetal Anomaly: Womens Intentions and Experiences 1 to 7 Years after the Event. Geburtshilfe Frauenheilkd, 78, 160-166.
     
  23. Zeisler H, Llurba E, Chantraine FJ, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Schoedl M, Grill S, Hund M, Verlohren S (2018). The sFlt-1/PlGF Ratio: ruling out pre-eclampsia for up to 4 weeks and the value of retesting. Ultrasound Obstet Gynecol, 0, 0.
     
  24. Hammersen J, Wohlfart S, Goecke TW, Koninger A, Stepan H, Gallinat R, Morris S, Bucher K, Clarke A, Wunsche S, Beckmann MW, Schneider H, Faschingbauer F (2018). Reliability of prenatal detection of X-linked hypohidrotic ectodermal dysplasia by tooth germ sonography. Prenat Diagn, 0, 0.
     
  25. Hanschmidt F, Nagl M, Klingner J, Stepan H, Kersting A (2018). Abortion after diagnosis of fetal anomaly: Psychometric properties of a German version of the individual level abortion stigma scale. PLoS One, 13, 0.
     
  26. Hanschmidt F, Treml J, Klingner J, Stepan H, Kersting A (2018). Stigma in the context of pregnancy termination after diagnosis of fetal anomaly: associations with grief, trauma, and depression. Arch Womens Ment Health, 21, 391-399.
     
  27. Hanschmidt F, Hoffmann R, Klingner J, Kersting A, Stepan H (2018). Help-seeking Following Termination of Pregnancy after Diagnosis of Fetal Anomaly: Women's Intentions and Experiences 1 to 7 Years after the Event. Geburtshilfe Frauenheilkd, 78, 160-166.
     
  28. Stepan H, Hoffmann J (2018). Part no. V/ 11 Prediction of preeclampsia ? sFlt-1/ PLGF In: Shigeru Saito , Comprehensive Gynecology and Obstetrics - Preeclampsia (S. 175-198), Berlin: Springer Verlag.
     


  29. 2017


  30. Ratsch U, Kaiser T, Stepan H, Jank A (2017). Evaluation of bone marrow function with immature platelet fraction in normal pregnancy. Pregnancy Hypertens, 10, 70-73.
     
  31. Schrey-Petersen S, Stepan H (2017). Anti-angiogenesis and Preeclampsia in 2016. Curr Hypertens Rep, 19(1), 6.
     
  32. Wolf B, Monecke, A, Horn, LC, Thome U, Stepan H, Schrey-Petersen S (2017). Acute lymphoblastic congenital leukemia as a cause of perinatal death following massive cerebral hemorrhage. Case Reports in Perinatal Medicine, 6(1), 0053.
     
  33. Hoffmann J, Ossada V, Weber M, Stepan H (2017). An intermediate sFlt-1/PlGF ratio indicates an increased risk for adverse pregnancy outcome. Pregnancy Hypertens, 10, 165-170.
     
  34. Faber R, Stepan H (2017). Sonografische Beurteilung des unteren Uterinsegments in der Schwangerschaft. Frauenarzt, 58(10), 825-833.
     
  35. Verlohren S, Stepan H (2017). Re: Rational and irrational ratios. Ultrasound in Obstetrics and Gynecology , 49(1), 157-158.
     
  36. Weber M, Stepan H (2017). ASS und Heparin zur Prävention der Präeklampsie. Gynaekologische Praxis , 42, 212-218.
     
  37. Berg K, Kraemer JF, Riedl M, Stepan H, Kurths J, Wessel N (2017). Increased cardiorespiratory coordination in preeclampsia. Physiol Meas, 38(5), 912-924.
     
  38. Nagl M, Lehnig F, Stepan H, Wagner B, Kersting A (2017). Associations of childhood maltreatment with pre-pregnancy obesity and maternal postpartum mental health: a cross-sectional study. BMC Pregnancy Childbirth, 17(1), 391.
     
  39. Vatish M, Stepan H, Hund M, Verlohren S (2017). Re: Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks gestation. Ultrasound Obstet Gynecol, 49(5), 665-666.
     
  40. Berg K, Kraemer JF, Riedl M, Stepan H, Kurths J, Wessel N (2017). Increased cardiorespiratory coordination in preeclampsia. Physiol Meas, 38(5), 912-924.
     
  41. Kehl S, Dotsch J, Hecher K, Schlembach D, Schmitz D, Stepan H, Gembruch U (2017). Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No.?015/080, October 2016). Geburtshilfe Frauenheilkd, 77, 1157-1173.
     
  42. Schlembach D, Schleußner E, Stepan H (2017). Klinische Geburtsmedizin. In: Schlembach D., Schleußner, E., Stepan H, Klinische Geburtsmedizin. (S. 118), Berlin/ Boston: De Gruyter Verlag.
     


  43. 2016


  44. Ossada V, Jank A, Stepan H (2016). The impact of uterine curettage postpartum on maternal sFlt-1 concentration. J Perinat Med, 44(3), 351-354.
     
  45. Klein E, Schlembach D, Ramoni A, Langer E, Bahlmann F, Grill S, Schaffenrath H, van der Does R, Messinger D, Verhagen-Kamerbeek WD, Reim M, Hund M, Stepan H (2016). Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia. PLoS One, 11(5), e0156013.
     
  46. Hoffmann J, Thomassen K, Stumpp P, Grothoff M, Engel C, Kahn T, Stepan H (2016). New MRI Criteria for Successful Vaginal Breech Delivery in Primiparae. PLoS One, 11(8), e0161028.
     
  47. Stepan H, Hund M, Gencay M, Denk B, Dinkel C, Kaminski WE, Wieloch P, Semus B, Meloth T, Droge LA, Verlohren S (2016). A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome. Hypertens Pregnancy, 35(3), 295-305.
     
  48. Hoffmann J, Stepan H (2016). Bildgebende Diagnostik bei Zustand nach Sectio. Ther Umsch, 73(7), 425-430.
     
  49. Schrey S, Stepan H (2016). Pränatale epigenetische Prägung: Stand des Wissens. Dtsch Arztebl, 113(45), 2040-2044.
     
  50. Nagl M, Steinig J, Klinitzke G, Stepan H, Kersting A (2016). Childhood maltreatment and pre-pregnancy obesity: a comparison of obese, overweight, and normal weight pregnant women. Arch Womens Ment Health, 19(2), 355-365.
     
  51. Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, Wenger J, Lucchesi KJ, Tamez H, Lindner T, Fridman A, Thome U, Kribs A, Danner M, Hamacher S, Mallmann P, Stepan H, Benzing T (2016). Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. J Am Soc Nephrol, 27(3), 903-913.
     
  52. Singer J, Jank A, Amara S, Stepan PD, Kaisers U, Hoehne C (2016). Efficacy and Effects of Parenteral Pethidine or Meptazinol and Regional Analgesia for Pain Relief during Delivery. A Comparative Observational Study. Geburtshilfe Frauenheilkd, 76(9), 964-971.
     
  53. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dilba P, Schoedl M, Hund M, Verlohren S (2016). Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med, 374(1), 13-22.
     
  54. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dinkel C, Schoedl M, Dilba P, Hund M, Verlohren S (2016). Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia. Obstet Gynecol, 128(2), 261-269.
     
  55. Mozet C, Kuhnt T, Sattler B, Remmele J, Thome U, Stepan H, Kluge R, Dietz A, Knoedler M (2016). [Head and Neck Cancer in Pregnancy - Recommendations for Diagnosis and Therapy With Case Report]. Laryngorhinootologie, 95(10), 674-683.
     
  56. Nagl M, Steinig J, Klinitzke G, Stepan H, Kersting A (2016). Childhood maltreatment and pre-pregnancy obesity: a comparison of obese, overweight, and normal weight pregnant women. Arch Womens Ment Health, 19(2), 355-365.
     


  57. 2015


  58. Schrey S, Wurst U, Ebert T, Kralisch S, Drewlo S, Stepan H, Lossner U, Platz M, Kratzsch J, Stumvoll M, Fasshauer M (2015). The adipokine preadipocyte factor-1 is downregulated in preeclampsia and expressed in placenta. Cytokine, 75(2), 338-343.
     
  59. Stepan H, Herraiz I, Schlembach D, Verlohren S, Brennecke S, Chantraine F, Klein E, Lapaire O, Llurba E, Ramoni A, Vatish M, Wertaschnigg D, Galindo A (2015). Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol, 45(3), 241-246.
     
  60. Hund M, Verhagen-Kamerbeek W, Reim M, Messinger D, van der Does R, Stepan H (2015). Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia-the PreOS study protocol. Hypertens Pregnancy, 34(1), 102-115.
     
  61. Wunsche S, Jungert J, Faschingbauer F, Mommsen H, Goecke T, Schwanitz K, Stepan H, Schneider H (2015). Noninvasive Prenatal Diagnosis of Hypohidrotic Ectodermal Dysplasia by Tooth Germ Sonography. Ultraschall Med, 36(4), 381-385.
     
  62. Droge L, Herraiz I, Zeisler H, Schlembach D, Stepan H, Kussel L, Henrich W, Galindo A, Verlohren S (2015). Maternal serum s-Flt-1/PlGF-ratio in twin pregnancies with and without preeclampsia in comparison to singleton pregnancies. Ultrasound Obstet Gynecol, 45(3), 286-293.
     
  63. Gross MM, Matterne A, Berlage S, Kaiser A, Lack N, Macher-Heidrich S, Misselwitz B, Bahlmann F, Falbrede J, Hillemanns P, von Kaisenberg C, von Koch FE, Schild RL, Stepan H, Devane D, Mikolajczyk R (2015). Interinstitutional variations in mode of birth after a previous caesarean section: a cross-sectional study in six German hospitals. J Perinat Med, 43(2), 177-184.
     
  64. Nagl M, Linde K, Stepan H, Kersting A (2015). Obesity and anxiety during pregnancy and postpartum: A systematic review. J Affect Disord, 186, 293-305.
     
  65. Platz M, Stepan H, Schrey S, Kralisch S, Wurst U, Lossner U, Jessnitzer B, Kratzsch J, Stumvoll M, Fasshauer M, Ebert T (2015). Serum levels of sclerostin in cardiometabolic disorders during pregnancy. Cytokine, 76(2), 591-593.
     
  66. Runge J, Riedl M, Muller A, Stepan H, Kurths J, Wessel N (2015). Quantifying the causal strength of multivariate cardiovascular couplings with momentary information transfer. Physiol Meas, 36(4), 813-825.
     
  67. Dhein S, Wermke A, von Salisch S, Schlegel F, Stepan H, Dohmen PM, Kostelka M, Mohr FW (2015). Autocrine control of angiogenesis by endogenous acetylcholine in an in vitro model using human endothelial cells: evidence for an autocrine cholinergic system in endothelial cells. J Cardiovasc Pharmacol, 65(5), 508-515.
     


  68. 2014


  69. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J, Markfeld-Erol F, Galindo A, Schoofs K, Denk B, Stepan H (2014). New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension, 63(2), 346-352.
     
  70. Schaarschmidt W, Stepan H (2014). Reply to: hepatic rupture - a rare but serious complication of HELLP syndrome. J Perinat Med, 42(2), 263-264.
     
  71. Hund M, Allegranza D, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H (2014). Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth, 14, 324.
     
  72. Walther T, Voss A, Baumert M, Truebner S, Till H, Stepan H, Wessel N, Faber R (2014). Cardiovascular variability before and after delivery: recovery from arterial stiffness in women with preeclampsia 4days post partum. Hypertens Pregnancy, 33(1), 1-14.
     
  73. Husse S, Gottschlich A, Schrey S, Stepan H, Hoffmann J (2014). [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients]. Z Geburtshilfe Neonatol, 218(1), 34-41.
     
  74. Viehweger A, Riffert T, Dhital B, Knosche TR, Anwander A, Stepan H, Sorge I, Hirsch W (2014). The Gini coefficient: a methodological pilot study to assess fetal brain development employing postmortem diffusion MRI. Pediatr Radiol, 44(10), 1290-1301.
     
  75. Andreotti F, Riedl M, Himmelsbach T, Wedekind D, Wessel N, Stepan H, Schmieder C, Jank A, Malberg H, Zaunseder S (2014). Robust fetal ECG extraction and detection from abdominal leads. Physiol Meas, 35(8), 1551-1567.
     
  76. Schubert RA, Schleussner E, Hoffmann J, Fiedler A, Stepan H, Gottschlich A (2014). [Prevention of preterm birth by Shirodkar cerclage--clinical results of a retrospective analysis]. Z Geburtshilfe Neonatol, 218(4), 165-170.
     
  77. Ebert T, Stepan H, Schrey S, Kralisch S, Hindricks J, Hopf L, Platz M, Lossner U, Jessnitzer B, Drewlo S, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine, 65(2), 153-158.
     


  78. 2013


  79. Faber R, Risse S, Steinke H, Thome U, Stepan H (2013). Monochorionic quadruplet pregnancy without severe complications: sonographic workup and placental findings. Letter. Ultrasound Obstet Gynecol, 41(6), 707-708.
     
  80. Stepan H, Kley K, Hindricks J, Kralisch S, Jank A, Schaarschmidt W, Schrey S, Ebert T, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Richter J, Fasshauer M (2013). Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Cytokine, 62(2), 322-326.
     
  81. Stepan H, Richter J, Kley K, Kralisch S, Jank A, Schaarschmidt W, Ebert T, Lossner U, Jessnitzer B, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2013). Serum levels of growth arrest specific protein 6 are increased in preeclampsia. Regul Pept, 182, 7-11.
     
  82. Schaarschmidt W, Rana S, Stepan H (2013). The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med, 41(5), 511-516.
     
  83. Ramirez Avila GM, Gapelyuk A, Marwan N, Walther T, Stepan H, Kurths J, Wessel N (2013). Classification of cardiovascular time series based on different coupling structures using recurrence networks analysis. Philos Trans A Math Phys Eng Sci, 371(1997), 20110623.
     
  84. Ramirez Avila GM, Gapelyuk A, Marwan N, Stepan H, Kurths J, Walther T, Wessel N (2013). Classifying healthy women and preeclamptic patients from cardiovascular data using recurrence and complex network methods. Auton Neurosci, 178(1), 103-110.
     


  85. 2012


  86. Stepan H, Philipp A, Roth I, Kralisch S, Jank A, Schaarschmidt W, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2012). Serum levels of the adipokine zinc-alpha2-glycoprotein are increased in preeclampsia. J Endocrinol Invest, 35(6), 562-5.
     
  87. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H (2012). The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol, 206(1), e1-8.
     
  88. Jank A, Kratzsch J, Stepan H (2012). Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregnancy, 31(2), 201-206.
     
  89. Tallarek AC, Stepan H (2012). [Preeclampsia and HELLP syndrome as an obstetric emergency]. Med Klin Intensivmed Notfmed, 107(2), 96-100.
     
  90. Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H (2012). The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem, 58(5), 837-845.
     
  91. Tallarek AC, Stepan H (2012). HELLP-Syndrom - klinisches Chamäleon und geburtshilflicher Notfall. Geburtshilfe und Frauenheilkunde, 72(1), 27-29.
     
  92. Stepan H (2012). Behandlung der Präeklampsie - mithilfe der Blutwäsche. Geburtshilfe und Frauenheilkunde, 72, 580-582.
     
  93. Tallarek AC, Huppertz B, Stepan H (2012). Präeklampsie - Ätiologie, aktuelle Diagnostik und klinisches Management, neue Therapieoptionen und Zukunftsaussichten. Geburtshilfe und Frauenheilkunde, 72(12), 1107-1116.
     
  94. Gartner C, Ziegelhoffer B, Kostelka M, Stepan H, Mohr FW, Dhein S (2012). Knock-down of endothelial connexins impairs angiogenesis. Pharmacol Res, 65(3), 347-57.
     
  95. Pecks U, Schutt A, Rower C, Reimer T, Schmidt M, Preschany S, Stepan H, Rath W, Glocker MO (2012). A mass spectrometric multicenter study supports classification of preeclampsia as heterogeneous disorder. Hypertens Pregnancy, 31(2), 278-291.
     
  96. Nickisch S, Kratzsch J, Gebauer C, Waldeyer T, Stepan H, Kiess W (2012). Glucose tolerance in women 24 h postpartum is related to blood pressure, anthropometric data, and adipokine serum levels. Hypertens Pregnancy, 31(2), 228-239.
     
  97. Verlohren S, Stepan H, Dechend R (2012). Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond), 122(2), 43-52.
     
  98. Miehle K, Stepan H, Fasshauer M (2012). Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf), 76(1), 2-11.
     
  99. Duerrschmidt N, Hagen A, Gaertner C, Wermke A, Nowicki M, Spanel-Borowski K, Stepan H, Mohr FW, Dhein S (2012). Nicotine effects on human endothelial intercellular communication via α4β2 and α3β2 nicotinic acetylcholine receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol, 385(6), 621-632.
     
  100. Wilhelm M, Hirsch W, Merkenschlager A, Stepan H, Geyer C, Kiess W (2012). A rare case of congenital choroid plexus carcinoma. Pediatr Hematol Oncol, 29(7), 643-646.
     
  101. Stepan H, Faber R, Heling KS, Hirsch W, Jank A, Sorge I (2012). Innovative Diagnostik in der Geburtsmedizin. In: Stepan H, Innovative Diagnostik in der Geburtsmedizin. (S. 1-89), Bremen: UNI-MED.
     


  102. 2011


  103. Stepan H, Philipp A, Roth I, Kralisch S, Jank A, Schaarschmidt W, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul Pept, 168(1-3), 69-72.
     
  104. Jank A, Schaarschmidt W, Stepan H (2011). Effect of steroids on angiogenic factors in pregnant women with HELLP syndrome. J Perinat Med, 39(5), 611-613.
     
  105. Petzold K, Jank A, Faber R, Stepan H (2011). Relation between maternal angiogenic factors and utero-placental resistance in normal first- and second-trimester pregnancies. Hypertens Pregnancy, 30(4), 401-407.
     
  106. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing (2011). Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation, 124(8), 940-950.
     


  107. 2010


  108. Stepan H, Kralisch S, Klostermann K, Schrey S, Reisenbuchler C, Verlohren M, Verlohren HJ, Drynda K, Bluher M, Stumvoll M, Kratzsch J, Kovacs P, Fasshauer M (2010). Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism, 59(7), 1054-1056.
     
  109. Stepan H, Philipp A, Reiche M, Klostermann K, Schrey S, Reisenbüchler C, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M (2010). Serum levels of the adipokine lipocalin-2 are increased in preeclampsia. J Endocrinol Invest, 33(9), 629-632.
     
  110. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H (2010). An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol, 202(2), 161e1-e11.
     
  111. Mayer S, Till H, Stepan H (2010). EXIT procedure in a neonate with a prenatally diagnosed granular cell tumor. Pediatr Surg Int, 26(9), 935-937.
     
  112. Lapaire O, Shennan A, Stepan H (2010). The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol, 151(2), 122-129.
     
  113. Stepan H, Schaarschmidt W, Jank A, Verlohren S, Kratzsch J (2010). [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience]. Z Geburtshilfe Neonatol, 214(6), 234-238.
     
  114. Stein S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism, 59(1), 33-37.
     
  115. Pfau D, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr, 74(1), 56-61.
     
  116. Riedl M, Suhrbier A, Stepan H, Kurths J, Wessel N (2010). Short-term couplings of the cardiovascular system in pregnant women suffering from pre-eclampsia. Philos Transact A Math Phys Eng Sci, 368(1918), 2237-2250.
     
  117. Stepan H (2010). Physiologie des mütterlichen Organismus und Anpassungsvorgänge in der Schwangerschaft. In: Rath W, Gembruch U, Schmidt S, Geburtshilfe und Perinatalmedizin. (S. 21-31), Stuttgart: Thieme Verlag.
     


  118. 2009


  119. Stepan H, Ebert T, Schrey S, Reisenbuchler C, Stein S, Lossner U, Bluher M, Stumvoll M, Kratzsch J, Faber R, Fasshauer M (2009). Serum Levels of Angiopoietin-Related Growth Factor Are Increased in Preeclampsia. Am J Hypertens, 22(3), 314-318.
     
  120. Stepan H (2009). Angiogenic factors and pre-eclampsia: an early marker is needed. Clin Sci (Lond), 116(3), 231-232.
     
  121. Stepan H, Ebert T, Schrey S, Reisenbüchler C, Stein S, Blüher M, Stumvoll M, Kratzsch J, Tönnessen P, Faber R, Fasshauer M (2009). Preliminary report: Serum levels of retinol-binding protein 4 in preeclampsia. Metabolism, 58(3), 275-277.
     
  122. Stepan H, Jank A (2009). [Angiogenic factors and their role in pathogenesis and prediction of preeclampsia] Z Geburtshilfe Neonatol, 213(3), 101-105.
     
  123. Stepan H (2009). Mütterliche Langzeitmorbidität nach Präeklampsie erhöht. Frauenarzt, 50(4), 328-335.
     
  124. Klostermann K, Stepan H (2009). Bildzitat: Variköse Cervix uteri bei Placenta percreta. Frauenarzt, 50(5), 440.
     
  125. Kralisch S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol, 160(1), 33-38.
     
  126. Sommer G, Kralisch S, Stangl V, Vietzke A, Kohler U, Stepan H, Faber R, Schubert A, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem, 106(4), 729-737.
     
  127. Koelsch S, Wiebigke C, Siebel WA, Stepan H (2009). Impulsive aggressiveness of pregnant women affects the development of the fetal heart. Int J Psychophysiol, 74(3), 243-249.
     
  128. Unger S, Weigel JF, Stepan H, Baerwald CG (2009). A case of maternal PKU syndrome despite intensive patient counseling. Wien Med Wochenschr, 159(19-20), 507-510.
     
  129. Mühler K, Pulzer F, Robel-Tillig E, Knüpfer M, Gebauer C, Keller A, Nickel P, Stepan H, Till H, Kiess W (2009). Case-Management in der psychosozialen Begleitung von Eltern Frühgeborener und kranker Neugeborener. Kinder- und Jugendmedizin, 9(2), 71-72.
     


  130. 2008


  131. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Serum levels of the adipokine visfatin are increased in preeclampsia. Clin Endocrinol, 69(1), 69-73.
     
  132. Horn LC, Purz S, Leo C, Stepan H (2008). Application of tissue microarrays in placental research. Ann Diagn Pathol, 12(1), 48-49.
     
  133. Walther T, Jank A, Heringer-Walther S, Horn LC, Stepan H (2008). Angiotensin II type 1 receptor has impact on murine placentation. Placenta, 29(10), 905-909.
     
  134. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia. J Hypertens, 26(9), 1824-1828.
     
  135. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens, 21(5), 582-586.
     
  136. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol, 158(2), 197-201.
     
  137. Stepan H, Geipel A, Schwarz F, Kramer T, Wessel N, Faber R (2008). Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol, 198(2), 175.e1-6.
     
  138. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf), 69(1), 69-73.
     
  139. Dornhöfer N, Stepan H (2008). Preeclampsia - more than a pregnancy complication Human Ontogenetics, 2, 29-38.
     
  140. Dornhöfer N, Baier D, Faber R, Stepan H (2008). Uterusverletzung mit Folgen Gynäkologe, 41(10), 830-832.
     
  141. Kralisch S, Sommer G, Stangl V, Köhler U, Kratzsch J, Stepan H, Faber R, Schubert A, Lössner U, Vietzke A, Bluher M, Stumvoll M, Fasshauer M (2008). Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB. Atherosclerosis, 196(2), 523-531.
     
  142. Rotzoll DE, Scherling R, Etzl R, Stepan H, Horn LC, Poschl JM (2008). Immunohistochemical localization of alpha-tocopherol transfer protein and lipoperoxidation products in human first-trimester and term placenta. Eur J Obstet Gynecol Reprod Biol, 140(2), 183-191.
     
  143. Stepan H (2008). Mutter und Kind im Wochenbett. In: Kiechle M, Repetitorium Gynäkologie und Geburtshilfe. (S. 176-188), München: Urban & Fischer Verlag.
     


  144. 2007


  145. Stepan H, Wallukat G, Schultheiss HP, Faber R, Walther T (2007). Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? J Reprod Immunol, 73(2), 130-134.
     
  146. Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H (2007). Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf), 66(3), 434-439.
     
  147. Stepan H, Faber R (2007). Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol, 109(5), 1205-1206.
     
  148. Stepan H, Unversucht A, Wessel N, Faber R (2007). Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension, 49(4), 818-824.
     
  149. Stepan H (2007). Translationale Forschung in der Geburtsmedizin: Beispiel angiogene Faktoren und Präeklampsie Geburtsh Frauenheilk, 67(8), 878-882.
     
  150. Walther T, Stepan H (2007). Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders. Curr Hypertens Rep, 9(2), 128-132.
     
  151. Stepan H, Walther T (2007). Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension, 50(1), e3.
     
  152. Stepan H, Kramer T, Faber R (2007). Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab, 92(7), 2831-2834.
     
  153. Malberg H, Bauernschmitt R, Voss A, Walther T, Faber R, Stepan H, Wessel N (2007). Analysis of cardiovascular oscillations: a new approach to the early prediction of pre-eclampsia. Chaos, 17(1), 015113 ff.
     
  154. Wang Y, de Waard MC, Sterner-Kock A, Stepan H, Schultheiss HP, Duncker DJ, Walther T (2007). Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail, 9(6-7/, 548-557.
     
  155. Stepan H (2007). Intrauterine Wachstumsretardierung. In: Wacker J, Sillem M, Bastert G, Beckmann M, Therapiehandbuch Gynäkologie und Geburtshilfe. (S. 45-50), Heidelberg: Springer Verlag.
     
  156. Stepan H (2007). Dopplersonographie. In: Wacker J, Sillem M, Bastert G, Beckmann M, Therapiehandbuch Gynäkologie und Geburtshilfe. (S. 51-57), Heidelberg: Springer Verlag.
     


  157. 2006


  158. Stepan H, Faber R (2006). Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med, 354(17), 1857-1858.
     
  159. Stepan H, Faber R, Wessel N, Wallukat G, Schultheiss HP, Walther T (2006). Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab, 91(6), 2424-2427.
     
  160. Walther T, Wessel N, Malberg H, Voss A, Stepan H, Faber R (2006). A combined technique for predicting pre-eclampsia: concurrent measurement of uterine perfusion and analysis of heart rate and blood pressure variability. J Hypertens, 24(4), 747-750.
     
  161. Voss A, Baumert M, Baier V, Stepan H, Walther T, Faber R (2006). Autonomic cardiovascular control in pregnancies with abnormal uterine perfusion. Am J Hypertens, 19(3), 306-312.
     
  162. Stepan H, Faber R, Dornhofer N, Huppertz B, Robitzki A, Walther T (2006). New insights into the biology of preeclampsia. Biol Reprod, 74(5), 772-776.
     
  163. Stepan H, Scheithauer S, Dornhofer N, Kramer T, Faber R (2006). Obesity as an obstetric risk factor: does it matter in a perinatal center? Obesity (Silver Spring), 14(5), 770-773.
     
  164. Stepan H, Nordmeyer AK, Faber R (2006). Proteinuria in hypertensive pregnancy diseases is associated with a longer persistence of hypertension postpartum. J Hum Hypertens, 20(2), 125-128.
     
  165. Horn LC, Faber R, Stepan H, Simon E, Robel R, Wittekind C (2006). Umbilical cord hypercoiling and thinning: a rare cause of intrauterine death in the second trimester of pregnancy. Pediatr Dev Pathol, 9(1), 20-24.
     
  166. Stepan H, (2006). Mutter und Kind im Wochenbett. In: Kiechle M, Gynäkologie und Geburtshilfe. (S. 447-468), München: Urban & Fischer.
     


  167. 2005


  168. Stepan H, Leo C, Purz S, Hockel M, Horn LC (2005). Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol, 122(2), 172-176.
     
  169. Horn LC, Faber S, Einenkel J, Gilks CB, Richter CE, Stepan H, Purz S, Krumpe C, Leo C (2005). Der Einsatz von Tissue Microarrays (TMA) - eine neue Technik in der gynäkologischen Tumorforschung. Geburtsh Frauenheilk, 65(1), 23-29.
     
  170. Walther T, Wallukat G, Jank A, Bartel S, Schultheiss HP, Faber R, Stepan H (2005). Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension, 46(6), 1275-1279.
     
  171. Stepan H, Faber R (2005). Urinary angiogenic factors in preeclampsia. Am J Obstet Gynecol, 193(6), 2181-2.
     
  172. Walther T, Wessel N, Baumert M, Stepan H, Voss A, Faber R (2005). Longitudinal analysis of heart rate variability in chronic hypertensive pregnancy. Hypertens Res, 28(2), 113-118.
     
  173. Rothermel A, Kurz R, Ruffer M, Weigel W, Jahnke HG, Sedello AK, Stepan H, Faber R, Schulze-Forster K, Robitzki AA (2005). Cells on a chip--the use of electric properties for highly sensitive monitoring of blood-derived factors involved in angiotensin II type 1 receptor signalling. Cell Physiol Biochem, 16, 51-58.
     


  174. 2004


  175. Walther T, Stepan H (2004). C-type natriuretic peptide in reproduction, pregnancy and fetal development. J Endocrinol, 180(1), 17-22.
     
  176. Stepan H, Faber R, Froster UG, Heinritz W, Wallaschofski H, Dechend R, Walther T, Huppertz B (2004). Pre-eclampsia as a 'three stage problem'--a workshop report. Placenta, 25(6), 585-587.
     
  177. Stepan H, Heihoff-Klose A, Faber R (2004). Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion. Ultrasound Obstet Gynecol, 23(6), 579-583.
     
  178. Faber R, Stepan H (2004). Umbilical cord entanglement in monoamniotic twins. Ultrasound Obstet Gynecol, 24(5), 592-593.
     
  179. Faber R, Stepan H, Baumert M, Voss A, Walther T (2004). Analysis of blood pressure waveform: a new method for the classification of hypertensive pregnancy disorders. J Hum Hypertens, 18(2), 135-137.
     
  180. Faber R, Baumert M, Stepan H, Wessel N, Voss A, Walther T (2004). Baroreflex sensitivity, heart rate, and blood pressure variability in hypertensive pregnancy disorders. J Hum Hypertens, 18(10), 707-712.
     
  181. Faber R, Stepan H, Baumert M, Voss A, Walther T (2004). Changes of blood pressure and heart rate variability precede a grand mal seizure in a pregnant woman. J Perinat Med, 32(6), 538-540.
     
  182. Glasow S, Stepan H, Sack U, Faber R (2004). Cervical immunoglobulin A and altered vaginal flora in pregnant women with threatened preterm delivery. J Perinat Med, 32(1), 37-41.
     
  183. Stepan H, Faber R (2004). [Abnormal uterine perfusion in the second trimester - current pathophysiological, diagnostic and therapeutic aspects.] Z Geburtshilfe Neonatol, 208(6), 205-209.
     
  184. Stepan H, Geide A, Faber R (2004). Soluble fms-like tyrosine kinase 1. N Engl J Med, 351(21), 2241-2242.
     
  185. Walther T, Stepan H, Pankow K, Becker M, Schultheiss HP, Siems WE (2004). Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide. Biol Chem, 385(2), 179-184.
     
  186. Walther T, Stepan H, Pankow K, Gembardt F, Faber R, Schultheiss HP, Siems WE (2004). Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus. BJOG, 111(5), 452-455.
     
  187. Wallaschofski H, Kobsar A, Sokolova O, Siegemund A, Stepan H, Faber R, Eigenthaler M, Lohmann T (2004). Differences in platelet activation by prolactin and leptin. Horm Metab Res, 36(7), 453-457.
     
  188. Wallenborn J, Rohrbach A, Stepan H, Kühnert I, Olthoff D (2004). Das peripartale Lungenödem - Anästhesiologische Aspekte eines geburtshilflichen Notfalls Anästh Intensivmed, 45(6), 341-350.